Pharmacokinetic interaction of flecainide and paroxetine in relation to the CYP2D6*10 allele in healthy Korean subjects
about
Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trialsThe Use of Gene Ontology Term and KEGG Pathway Enrichment for Analysis of Drug Half-LifeCytochrome P450-2D6 Genotype Definition May Improve Therapy for Paroxysmal Atrial Fibrillation A Case of Syncope Following "Pill-in-the-Pocket" Quinidine plus Propafenone.Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide.Impact of genetic polymorphism on drug-drug interactions mediated by cytochromes: a general approach.
P2860
Pharmacokinetic interaction of flecainide and paroxetine in relation to the CYP2D6*10 allele in healthy Korean subjects
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetic interaction of ...... ele in healthy Korean subjects
@en
Pharmacokinetic interaction of ...... le in healthy Korean subjects.
@nl
type
label
Pharmacokinetic interaction of ...... ele in healthy Korean subjects
@en
Pharmacokinetic interaction of ...... le in healthy Korean subjects.
@nl
prefLabel
Pharmacokinetic interaction of ...... ele in healthy Korean subjects
@en
Pharmacokinetic interaction of ...... le in healthy Korean subjects.
@nl
P2093
P2860
P1476
Pharmacokinetic interaction of ...... ele in healthy Korean subjects
@en
P2093
Bo-Hyung Kim
In-Jin Jang
JaeWoo Kim
Ji-Young Jeon
Joo-Youn Cho
Kyoung Soo Lim
Kyung-Sang Yu
Sang-Goo Shin
SoJeong Yi
P2860
P304
P356
10.1111/J.1365-2125.2008.03267.X
P407
P50
P577
2008-07-24T00:00:00Z